Evidence map›Paper›PMID 40940942›Full record

ReviewCancers2025

Clinical Outcomes and Safety of Ultra-Low-Dose Radiotherapy for Ocular Adnexal Lymphoma: A Systematic Review.

Miloš Grujić, Stanislav Volchenkov, Aidos Akhmetali, Marija Živković Radojević, Neda Milosavljević, Katarina Janković, Katarina Krasić, Milica Mihajlović, Mohamed Shelan, Luca Nicosia and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Salvage ultra-low-dose radiotherapy for conjunctival mantle cell lymphoma - a case report and literature review.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Miloš GrujićCenter for Radiation Oncology, University Clinical Center Kragujevac, 34000 Kragujevac, Serbia.ORCID 0009-0000-9552-8649
Stanislav VolchenkovNational Medical Research Center of Oncology N.N. Petrov, 197758 St. Petersburg, Russia.
Aidos AkhmetaliOutpatient Care Department, Hematology Center LLP, Karaganda Medical University, Karaganda 100000, Kazakhstan.ORCID 0009-0000-7735-549X
Marija Živković RadojevićCenter for Radiation Oncology, University Clinical Center Kragujevac, 34000 Kragujevac, Serbia.ORCID 0000-0003-2146-3381
Neda MilosavljevićCenter for Radiation Oncology, University Clinical Center Kragujevac, 34000 Kragujevac, Serbia.
Katarina JankovićCenter for Radiation Oncology, University Clinical Center Kragujevac, 34000 Kragujevac, Serbia.ORCID 0009-0002-7891-7962
Katarina KrasićCenter for Radiation Oncology, University Clinical Center Kragujevac, 34000 Kragujevac, Serbia.
Milica MihajlovićClinic for Oncology, University Clinical Center Nis, 18000 Nis, Serbia.
Mohamed ShelanDepartment of Radiation Oncology, Inselspital Bern, University of Bern, 3010 Bern, Switzerland.ORCID 0000-0002-6477-6655
Luca NicosiaAdvanced Radiation Oncology Department, IRCCS Sacro Cuore Don Calabria Hospital, Cancer Care Center, 37034 Verona, Italy.ORCID 0000-0002-0731-8041
Mladen MarinkovićClinic for Radiation Oncology, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0001-8437-3493

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

indolent lymphomalocal controlocular adnexal lymphomasystematic reviewtoxicityultra-low-dose radiationultra-low-dose radiotherapy

Identifiers

PMID40940942
PMCPMC12427289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.